ZR2 Followed by Immunochemotherapy in Elderly Patients With Newly-diagnosed DLBCL

Clinical trial NCT05290090 · UNKNOWN

Trial details

NCT number: NCT05290090
Sponsor: Zhejiang Cancer Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma

Start date: 2021-10-01
Primary completion: 2024-06-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.